4 printed issues of Nordic Life Science, the premium quality business magazine.

After more than four years of full-scale war waged by Russia in Ukraine, Ukrainians’ physical and mental health – and the entire healthcare system – are under extreme pressure. Today, relief efforts focus on knowledge transfer, new ways of managing and operating healthcare, and long-term partnerships, while also drawing lessons from Ukraine’s own resilience, crisis responses, and rehabilitation solutions.

The company has entered into the agreement with Eli Lilly and Company regarding a potential new treatment combining BioArctic’s BrainTransporter technology with an undisclosed Lilly drug candidate in neurodegeneration.

After 18 hours of traveling from Gothenburg I’m heading to the main hospital in Cherkasy, Ukraine, which is a reasonably-sized hospital with about 800 beds. Apart from their everyday business they have had an extra 30,000 or so soldiers to take care of since the war started. They are worn out. The staff members are really trying to hang in there. They’re running low on supplies but they’re not giving up.

Qlucore has received approval for a third payment of approximately EUR 0.5 million under its previously awarded EU grant. The total grant amounts to EUR 2.5 million and is distributed across four installments.